Pharma Foods International Co., Ltd. (TYO:2929)
657.00
-11.00 (-1.65%)
Feb 13, 2026, 3:30 PM JST
TYO:2929 Cash Flow Statement
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Net Income | 183 | 2,434 | 5,034 | 3,542 | 1,423 | 5,765 |
Depreciation & Amortization | 772 | 785 | 907 | 546 | 520 | 181 |
Loss (Gain) From Sale of Assets | -4 | - | 101 | - | -77 | - |
Loss (Gain) From Sale of Investments | 117 | 118 | 113 | 50 | 1 | - |
Loss (Gain) on Equity Investments | 81 | 131 | 35 | 82 | -5 | -16 |
Other Operating Activities | -2,679 | -1,894 | -437 | -1,006 | -2,954 | -177 |
Change in Accounts Receivable | -368 | -988 | 287 | 2,850 | -1,020 | -2,676 |
Change in Inventory | -1,407 | -1,133 | -649 | 12 | -2,247 | -1,071 |
Change in Accounts Payable | 357 | 466 | 420 | -418 | -676 | 2,957 |
Change in Other Net Operating Assets | -295 | -1,011 | -325 | 467 | -1,030 | 975 |
Operating Cash Flow | -3,243 | -1,092 | 5,486 | 6,125 | -6,065 | 5,938 |
Operating Cash Flow Growth | - | - | -10.43% | - | - | - |
Capital Expenditures | -890 | -891 | -841 | -386 | -467 | -154 |
Sale of Property, Plant & Equipment | 9 | - | -101 | 3 | 306 | - |
Cash Acquisitions | - | - | - | - | -1,599 | - |
Sale (Purchase) of Intangibles | -16 | -15 | -31 | -19 | -5 | -19 |
Investment in Securities | -133 | -64 | -410 | -600 | -721 | -200 |
Other Investing Activities | 14 | 20 | -7 | -11 | -53 | -92 |
Investing Cash Flow | -1,016 | -950 | -1,390 | -1,013 | -2,539 | -442 |
Short-Term Debt Issued | - | - | - | 2,000 | 12,100 | 2,500 |
Long-Term Debt Issued | - | - | 300 | 2,000 | - | - |
Total Debt Issued | 2,500 | - | 300 | 4,000 | 12,100 | 2,500 |
Short-Term Debt Repaid | - | -3,500 | -2,500 | - | - | - |
Long-Term Debt Repaid | - | -760 | -1,005 | -760 | -3,243 | -1,180 |
Total Debt Repaid | -1,177 | -4,260 | -3,505 | -760 | -3,243 | -1,180 |
Net Debt Issued (Repaid) | 1,323 | -4,260 | -3,205 | 3,240 | 8,857 | 1,320 |
Issuance of Common Stock | 761 | 761 | - | 2 | 5 | 8 |
Repurchase of Common Stock | -175 | -175 | -999 | -300 | -299 | - |
Common Dividends Paid | -723 | -784 | -626 | -578 | -871 | -290 |
Other Financing Activities | -11 | -9 | -12 | -23 | -13 | -8 |
Financing Cash Flow | 1,175 | -4,467 | -4,842 | 2,341 | 7,679 | 1,030 |
Foreign Exchange Rate Adjustments | - | - | 5 | 5 | -22 | -14 |
Miscellaneous Cash Flow Adjustments | - | - | 2 | 2 | -1 | -1 |
Net Cash Flow | -3,084 | -6,509 | -739 | 7,460 | -948 | 6,511 |
Free Cash Flow | -4,133 | -1,983 | 4,645 | 5,739 | -6,532 | 5,784 |
Free Cash Flow Growth | - | - | -19.06% | - | - | - |
Free Cash Flow Margin | -6.23% | -3.04% | 7.47% | 8.37% | -10.85% | 12.37% |
Free Cash Flow Per Share | -143.17 | -68.99 | 163.32 | 198.74 | -225.13 | 198.99 |
Cash Interest Paid | 92 | 91 | 62 | 48 | 29 | 11 |
Cash Income Tax Paid | 2,359 | 2,247 | 685 | 1,068 | 3,028 | 224 |
Levered Free Cash Flow | -2,369 | -1,259 | 4,292 | 5,195 | -6,726 | 5,540 |
Unlevered Free Cash Flow | -2,312 | -1,202 | 4,330 | 5,225 | -6,710 | 5,547 |
Change in Working Capital | -1,713 | -2,666 | -267 | 2,911 | -4,973 | 185 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.